INSM Q2 2018 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$30B

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$73M

Net Income

-$76M

EPS (Diluted)

$-1.00

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$55M

Free Cash Flow

-$58M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$724M

Total Liabilities

$354M

Stockholders' Equity

$371M

Cash & Equivalents

$634M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$73M	-$44M	-67.5%
Net Income	-$76M	-$45M	-71.1%